Trial

NCT02521246

Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
EMS
Collaborators
Condition
Essential Arterial Hypertension
Intervention
Candesartan + Chlorthalidone
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-19